Candidate Interventions for Integrating Hypertension and Cardiovascular-Kidney-Metabolic Care in Primary Health Settings: HEARTS 2.0 Phase 1
Background: HEARTS in the Americas is the regional adaptation of the WHO Global HEARTS Initiative, aimed at helping countries enhance hypertension and cardiovascular disease (CVD) risk management in primary care settings. Its core implementation tool, the HEARTS Clinical Pathway, has been adopted by...
- Autores:
-
Rosende, Andres
Romero, Cesar
DiPette, Donald
Brettler, Jeffrey
Van der Stuyft, Patrick
Satheesh, Gautam
Perel, Pablo
Chapman, Niamh
Moran, Andrew
Schutte, Aletta
Sharman, James
IRAZOLA, VILMA
Huffman, Mark
Campbell, Norm
Abdul Salam, Mohammad
Lanas, Fernando
Coca, Antonio
Garcia-Zamora, Sebastian
FERREIRO, ALEJANDRO
Lopez-Jaramillo, Patricio
Rico-Fontalvo, Jorge
Ridley, Emily
Picone, Dean
Flood, David
Piñeiro, Daniel José
Neira Ojeda, Carolina
Rodriguez, Gonzalo
Wellmann, Irmgardt A.
Orias, Marcelo
Rivera, Marcela
Villatoro, Matías
Onuma, Oyere
RAMROOP, SHAUN
Khan, Taskeen
Valdés González, Yamilé
Sebba Barroso Souza, Weimar Kunz
Plavnik, Frida
Zúñiga, Eric
Grassani, Ana María
Tajer, Carlos
Zaidel, Ezequiel J
MARIN, MARCOS
Cyr Philbert, Shana
amorin, ignacio
Diaz-Aguilera, Miguel Angel
Bortolotto, Luiz
AVEZUM, ALVARO
Ribeiro, Antonio
Tobe, Sheldon
Aumala Viscarra, Teresa Natalia
Angell, Sonia
Lavados, Pablo
Martins, Sheila
Munera, Ana
Jaffe, Marc
Prabhakaran, Dorairaj
Parati, Gianfranco
Zhang, Xin-Hua
Rodgers, Anthony
Yusuf, Salim
Whelton, Paul
Ordunez, Pedro
- Tipo de recurso:
- Fecha de publicación:
- 2025
- Institución:
- Universidad Simón Bolívar
- Repositorio:
- Repositorio Digital USB
- Idioma:
- eng
- OAI Identifier:
- oai:bonga.unisimon.edu.co:20.500.12442/16630
- Acceso en línea:
- https://hdl.handle.net/20.500.12442/16630
https://doi.org/10.5334/gh.1428
https://globalheartjournal.com/articles/1428/files/683599615fc84.pdf
- Palabra clave:
- Hypertension
Primary Health Care
Cardiovascular Diseases
Diabetes mellitus
Renal Insufficiency
Chronic
Stroke
- Rights
- openAccess
- License
- Attribution-NonCommercial-NoDerivatives 4.0 International
id |
USIMONBOL2_a373e330ecab598ced2ba4d6b43f5b80 |
---|---|
oai_identifier_str |
oai:bonga.unisimon.edu.co:20.500.12442/16630 |
network_acronym_str |
USIMONBOL2 |
network_name_str |
Repositorio Digital USB |
repository_id_str |
|
dc.title.eng.fl_str_mv |
Candidate Interventions for Integrating Hypertension and Cardiovascular-Kidney-Metabolic Care in Primary Health Settings: HEARTS 2.0 Phase 1 |
title |
Candidate Interventions for Integrating Hypertension and Cardiovascular-Kidney-Metabolic Care in Primary Health Settings: HEARTS 2.0 Phase 1 |
spellingShingle |
Candidate Interventions for Integrating Hypertension and Cardiovascular-Kidney-Metabolic Care in Primary Health Settings: HEARTS 2.0 Phase 1 Hypertension Primary Health Care Cardiovascular Diseases Diabetes mellitus Renal Insufficiency Chronic Stroke |
title_short |
Candidate Interventions for Integrating Hypertension and Cardiovascular-Kidney-Metabolic Care in Primary Health Settings: HEARTS 2.0 Phase 1 |
title_full |
Candidate Interventions for Integrating Hypertension and Cardiovascular-Kidney-Metabolic Care in Primary Health Settings: HEARTS 2.0 Phase 1 |
title_fullStr |
Candidate Interventions for Integrating Hypertension and Cardiovascular-Kidney-Metabolic Care in Primary Health Settings: HEARTS 2.0 Phase 1 |
title_full_unstemmed |
Candidate Interventions for Integrating Hypertension and Cardiovascular-Kidney-Metabolic Care in Primary Health Settings: HEARTS 2.0 Phase 1 |
title_sort |
Candidate Interventions for Integrating Hypertension and Cardiovascular-Kidney-Metabolic Care in Primary Health Settings: HEARTS 2.0 Phase 1 |
dc.creator.fl_str_mv |
Rosende, Andres Romero, Cesar DiPette, Donald Brettler, Jeffrey Van der Stuyft, Patrick Satheesh, Gautam Perel, Pablo Chapman, Niamh Moran, Andrew Schutte, Aletta Sharman, James IRAZOLA, VILMA Huffman, Mark Campbell, Norm Abdul Salam, Mohammad Lanas, Fernando Coca, Antonio Garcia-Zamora, Sebastian FERREIRO, ALEJANDRO Lopez-Jaramillo, Patricio Rico-Fontalvo, Jorge Ridley, Emily Picone, Dean Flood, David Piñeiro, Daniel José Neira Ojeda, Carolina Rodriguez, Gonzalo Wellmann, Irmgardt A. Orias, Marcelo Rivera, Marcela Villatoro, Matías Onuma, Oyere RAMROOP, SHAUN Khan, Taskeen Valdés González, Yamilé Sebba Barroso Souza, Weimar Kunz Plavnik, Frida Zúñiga, Eric Grassani, Ana María Tajer, Carlos Zaidel, Ezequiel J MARIN, MARCOS Cyr Philbert, Shana amorin, ignacio Diaz-Aguilera, Miguel Angel Bortolotto, Luiz AVEZUM, ALVARO Ribeiro, Antonio Tobe, Sheldon Aumala Viscarra, Teresa Natalia Angell, Sonia Lavados, Pablo Martins, Sheila Munera, Ana Jaffe, Marc Prabhakaran, Dorairaj Parati, Gianfranco Zhang, Xin-Hua Rodgers, Anthony Yusuf, Salim Whelton, Paul Ordunez, Pedro |
dc.contributor.author.none.fl_str_mv |
Rosende, Andres Romero, Cesar DiPette, Donald Brettler, Jeffrey Van der Stuyft, Patrick Satheesh, Gautam Perel, Pablo Chapman, Niamh Moran, Andrew Schutte, Aletta Sharman, James IRAZOLA, VILMA Huffman, Mark Campbell, Norm Abdul Salam, Mohammad Lanas, Fernando Coca, Antonio Garcia-Zamora, Sebastian FERREIRO, ALEJANDRO Lopez-Jaramillo, Patricio Rico-Fontalvo, Jorge Ridley, Emily Picone, Dean Flood, David Piñeiro, Daniel José Neira Ojeda, Carolina Rodriguez, Gonzalo Wellmann, Irmgardt A. Orias, Marcelo Rivera, Marcela Villatoro, Matías Onuma, Oyere RAMROOP, SHAUN Khan, Taskeen Valdés González, Yamilé Sebba Barroso Souza, Weimar Kunz Plavnik, Frida Zúñiga, Eric Grassani, Ana María Tajer, Carlos Zaidel, Ezequiel J MARIN, MARCOS Cyr Philbert, Shana amorin, ignacio Diaz-Aguilera, Miguel Angel Bortolotto, Luiz AVEZUM, ALVARO Ribeiro, Antonio Tobe, Sheldon Aumala Viscarra, Teresa Natalia Angell, Sonia Lavados, Pablo Martins, Sheila Munera, Ana Jaffe, Marc Prabhakaran, Dorairaj Parati, Gianfranco Zhang, Xin-Hua Rodgers, Anthony Yusuf, Salim Whelton, Paul Ordunez, Pedro |
dc.subject.keywords.eng.fl_str_mv |
Hypertension Primary Health Care Cardiovascular Diseases Diabetes mellitus Renal Insufficiency Chronic Stroke |
topic |
Hypertension Primary Health Care Cardiovascular Diseases Diabetes mellitus Renal Insufficiency Chronic Stroke |
description |
Background: HEARTS in the Americas is the regional adaptation of the WHO Global HEARTS Initiative, aimed at helping countries enhance hypertension and cardiovascular disease (CVD) risk management in primary care settings. Its core implementation tool, the HEARTS Clinical Pathway, has been adopted by 28 countries. To improve the care of hypertension, diabetes, and chronic kidney disease (CKD), HEARTS 2.0 was developed as a three-phase process to integrate evidence-based interventions into a unified care pathway, ensuring consistency across fragmented guidelines. This paper focuses on Phase 1, highlighting targeted interventions to improve and update the HEARTS Clinical Pathway. Methods: First, the coordinating group defined the project’s scope, objectives, principles, methodological framework, and tools. Second, international experts from different disciplines proposed interventions to enhance the HEARTS Clinical Pathway. Third, the coordinating group harmonized these proposals into unique interventions. Fourth, experts appraised the appropriateness of the proposed interventions on a 1-to 9 scale using the adapted RAND/UCLA Appropriateness Method. Finally, interventions with a median score above 6 were deemed appropriate and selected as candidates to enhance the HEARTS Clinical Pathway. Results: Building on the existing HEARTS Clinical Pathway, 45 unique interventions were selected, including community-based screening, early detection and management of risk factors, lower blood pressure thresholds for diagnosing hypertension in high CVD-risk patients, reinforcement of single-pill combination therapy, inclusion of sodium-glucose cotransporter-2 inhibitors for patients with diabetes, CKD, or heart failure, expanded roles for non-physician health workers in team-based care, and strengthened clinical documentation, monitoring, and evaluation. |
publishDate |
2025 |
dc.date.accessioned.none.fl_str_mv |
2025-05-28T13:13:22Z |
dc.date.available.none.fl_str_mv |
2025-05-28T13:13:22Z |
dc.date.issued.none.fl_str_mv |
2025 |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
dc.type.driver.none.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.spa.none.fl_str_mv |
Artículo científico |
dc.identifier.citation.none.fl_str_mv |
Rosende A, Romero C, DiPette DJ, Brettler J, Van der Stuyft P, Satheesh G, Perel P, Chapman N, Moran AE, Schutte AE, Sharman JE, Irazola V, Huffman MD, Campbell NRC, Salam A, Lanas F, Coca A, Garcia-Zamora S, Ferreiro A, Lopez-Jaramillo P, Rico-Fontalvo J, Ridley E, Picone D, Flood D, Piñeiro DJ, Ojeda CN, Rodriguez G, Wellmann IA, Orias M, Rivera M, Reyes MV, Onuma O, Ramroop S, Khan T, Gonzalez YV, Barroso WKS, Plavnik FL, Zuniga E, Grassani AM, Tajer C, Zaidel E, Marin MJ, Cyr-Philbert S, Amorin I, Diaz Aguilera MA, Bortolotto L, Avezum A, Ribeiro ALP, Tobe S, Aumala T, Angell S, Lavados P, Martins SO, Echeverri AM, Jaffe MG, Prabhakaran D,Parati G, Zhang XH, Rodgers A, Yusuf S, Whelton PK, Ordunez P. Candidate Interventions for Integrating Hypertension and Cardiovascular-Kidney-Metabolic Care in Primary Health Settings: HEARTS 2.0 Phase 1. Global Heart. 2025; 20(1): 45. DOI: https://doi.org/10.5334/gh.1428 |
dc.identifier.issn.none.fl_str_mv |
22118179 (Electrónico) 22118160 (Impreso) |
dc.identifier.uri.none.fl_str_mv |
https://hdl.handle.net/20.500.12442/16630 |
dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.5334/gh.1428 |
dc.identifier.url.none.fl_str_mv |
https://globalheartjournal.com/articles/1428/files/683599615fc84.pdf |
identifier_str_mv |
Rosende A, Romero C, DiPette DJ, Brettler J, Van der Stuyft P, Satheesh G, Perel P, Chapman N, Moran AE, Schutte AE, Sharman JE, Irazola V, Huffman MD, Campbell NRC, Salam A, Lanas F, Coca A, Garcia-Zamora S, Ferreiro A, Lopez-Jaramillo P, Rico-Fontalvo J, Ridley E, Picone D, Flood D, Piñeiro DJ, Ojeda CN, Rodriguez G, Wellmann IA, Orias M, Rivera M, Reyes MV, Onuma O, Ramroop S, Khan T, Gonzalez YV, Barroso WKS, Plavnik FL, Zuniga E, Grassani AM, Tajer C, Zaidel E, Marin MJ, Cyr-Philbert S, Amorin I, Diaz Aguilera MA, Bortolotto L, Avezum A, Ribeiro ALP, Tobe S, Aumala T, Angell S, Lavados P, Martins SO, Echeverri AM, Jaffe MG, Prabhakaran D,Parati G, Zhang XH, Rodgers A, Yusuf S, Whelton PK, Ordunez P. Candidate Interventions for Integrating Hypertension and Cardiovascular-Kidney-Metabolic Care in Primary Health Settings: HEARTS 2.0 Phase 1. Global Heart. 2025; 20(1): 45. DOI: https://doi.org/10.5334/gh.1428 22118179 (Electrónico) 22118160 (Impreso) |
url |
https://hdl.handle.net/20.500.12442/16630 https://doi.org/10.5334/gh.1428 https://globalheartjournal.com/articles/1428/files/683599615fc84.pdf |
dc.language.iso.none.fl_str_mv |
eng |
language |
eng |
dc.rights.eng.fl_str_mv |
Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.rights.uri.none.fl_str_mv |
http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.rights.accessrights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ http://purl.org/coar/access_right/c_abf2 |
eu_rights_str_mv |
openAccess |
dc.format.mimetype.none.fl_str_mv |
pdf |
dc.publisher.eng.fl_str_mv |
Ubiquity Press |
dc.source.eng.fl_str_mv |
Global Heart |
dc.source.spa.fl_str_mv |
Vol. 20 No. 1, (2025) |
institution |
Universidad Simón Bolívar |
bitstream.url.fl_str_mv |
https://bonga.unisimon.edu.co/bitstreams/0d7dac3d-e85f-44b7-85a2-5cef8b960dc4/download https://bonga.unisimon.edu.co/bitstreams/2cdbb472-fb91-43a0-99e8-e3a12d11ca99/download https://bonga.unisimon.edu.co/bitstreams/9247e97b-15a1-463d-acf7-3451f8fc431b/download https://bonga.unisimon.edu.co/bitstreams/28f7a355-a6a1-4f5c-99cd-7588000d4c87/download https://bonga.unisimon.edu.co/bitstreams/96f415a9-d474-4429-8e80-39516f334c24/download |
bitstream.checksum.fl_str_mv |
757c89011daee329c899d390fcf67c41 3b6ce8e9e36c89875e8cf39962fe8920 733bec43a0bf5ade4d97db708e29b185 77c9f58d6a1c0c85d98821b5ba1c7a46 a02dd1c329763fc4017d6365b098c87a |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositorio Digital Universidad Simón Bolívar |
repository.mail.fl_str_mv |
repositorio.digital@unisimon.edu.co |
_version_ |
1834107444703264768 |
spelling |
Rosende, Andresea131903-be5a-485e-a0b3-cc4060cb8565600Romero, Cesar41841e7e-3b5e-44cc-88a4-4b4433bd9575-1DiPette, Donaldb04a2fdb-e94e-4344-90cd-130a413e298d600Brettler, Jeffrey18854b84-d29b-4919-99db-e7ae685c83f7600Van der Stuyft, Patrickd117ec0e-b046-4b82-8db7-da6f95612353600Satheesh, Gautamf173bbca-5137-4558-acdc-efc5a34d228d600Perel, Pablo28404f54-e848-4c64-9f01-7b7d5b6f9228-1Chapman, Niamh95e4e8cb-f658-40e4-955d-abba29c36f29600Moran, Andrew010c1e5d-32cd-4886-936b-3fcd4a52e2c6600Schutte, Aletta6fb8c7c3-1946-4833-9d6b-2fca855393df600Sharman, Jamese8d02683-837a-46d1-b6fe-d29423bbfaa2600IRAZOLA, VILMA06a3d788-bb25-4507-ae3f-4d436fe2b986600Huffman, Mark42ace21e-6dfc-439c-be4a-3bc98fd37c59600Campbell, Norma368114d-5d2d-4bcd-8f85-30387c526d71600Abdul Salam, Mohammad72dfbee8-6c0e-48ca-8cc8-91258fea0b1f600Lanas, Fernando1d98b1cf-442e-421c-b9cd-4dbc8695232a600Coca, Antonio50bbd5b9-5481-45f8-ac8a-0504e68b9253-1Garcia-Zamora, Sebastian0910c803-f3a6-47b0-97cf-9ab753620ff8600FERREIRO, ALEJANDROea4f7e7a-1114-4525-bb05-9cc35e809f88600Lopez-Jaramillo, Patricioa37068f9-7fb1-448e-ad04-7fba1c7d3067600Rico-Fontalvo, Jorgeaf74ba1f-e6ed-43b2-9067-6275b4ca7b0e600Ridley, Emily5240bd2f-6ff1-4b88-8035-1ab6b6f0d4f4600Picone, Deana92dd8bc-6713-4e7d-94d2-ce3360f54558600Flood, David62cb0239-d05a-401a-9e1a-d11224883e13600Piñeiro, Daniel José497358c1-c9c8-4740-9d2b-2c76797f2317-1Neira Ojeda, Carolinaeb3fc5ba-8e88-4ba8-8ad1-69eef378c172-1Rodriguez, Gonzalo683c259c-47a8-4170-b9bf-ea4266a8b22d-1Wellmann, Irmgardt A.91d3259c-51ed-4637-9651-3398def5303b600Orias, Marcelod8cc33fb-5fb2-4ccc-902b-bc80421e8e56600Rivera, Marcelacec3886f-95f8-4b0d-982d-07807bd99754-1Villatoro, Matías 739d61f1-ccca-418c-b25b-36d7c87bac28600Onuma, Oyere4cd814bf-c730-4e57-9d69-8a9006d9af6c600RAMROOP, SHAUN4fdaab90-ded3-4917-8951-e55783ea1d59600Khan, Taskeen6e4036df-2d9e-48ac-9731-f553edb1d27c600Valdés González, Yamiléaca868b3-967b-4a27-8cae-7a5aac729a3e600Sebba Barroso Souza, Weimar Kunz08fae44e-7402-4f67-be67-23eae7f8ce48-1Plavnik, Frida2670c67a-64f9-42c9-90af-2078451c2cdf600Zúñiga, Eric18d38f98-e8b4-472c-88cd-fc7b3a373c0e600Grassani, Ana María 49ca967a-c480-44c5-9064-496784a0b03e600Tajer, Carlosa6a6c687-0d19-4e19-92ed-c9df7917c170600Zaidel, Ezequiel Jfeb5f9e7-37ef-4df8-825a-171509788cc2-1MARIN, MARCOS46506ade-8142-4f91-8755-133c122d3eeb-1Cyr Philbert, Shanadd124d4b-0d90-4abd-bee1-e2aa738ab618-1amorin, ignacio3368bac8-8559-4d77-a9f7-33c2ccc47b63600Diaz-Aguilera, Miguel Angel1125e118-dd9d-402b-a2b1-a1e92aa70f2e600Bortolotto, Luiz23033a86-67d6-43ce-a256-344c8d55e6d8600AVEZUM, ALVARO9ee0fc7e-51ac-4ca9-bed8-dbc68243153d-1Ribeiro, Antonioe4d0a51d-d621-4894-9835-46a1b2cc9abf600Tobe, Sheldon7d1dc30b-c4c7-41d4-9bd6-9c458fcfb204600Aumala Viscarra, Teresa Natalia08c5ef66-78cc-424e-8635-1902806005dd600Angell, Sonia16dbaad9-35c5-4071-9780-b2c88f449ab9600Lavados, Pablo42b9f7cf-3f0d-42c2-8b95-0c39aa7a46f8600Martins, Sheila6d3e5caf-13e4-4b0d-b5c6-808249b0f9c3-1Munera, Anac8e8cbfc-56a3-4b30-b3aa-ec37dc946669600Jaffe, Marc9aa469c7-1e26-413a-86f3-db2e2592c715600Prabhakaran, Dorairaj0ac95e60-f833-4d33-9b2e-3d5dc48654ec-1Parati, Gianfranco5ac6fced-6f74-4107-9686-2850c3e7e55c600Zhang, Xin-Hua583b8beb-4903-4770-9318-9bf339d0af77600Rodgers, Anthony0a2db4aa-84ba-4d9e-aeff-9567af82d1f7600Yusuf, Salimac1183bd-fb78-4932-baf6-99ce8dc64a58600Whelton, Paul4304602a-015a-4fc2-a112-6596ebe84ec2600Ordunez, Pedro507f627d-956c-44f9-b7b4-8152f66687136002025-05-28T13:13:22Z2025-05-28T13:13:22Z2025Rosende A, Romero C, DiPette DJ, Brettler J, Van der Stuyft P, Satheesh G, Perel P, Chapman N, Moran AE, Schutte AE, Sharman JE, Irazola V, Huffman MD, Campbell NRC, Salam A, Lanas F, Coca A, Garcia-Zamora S, Ferreiro A, Lopez-Jaramillo P, Rico-Fontalvo J, Ridley E, Picone D, Flood D, Piñeiro DJ, Ojeda CN, Rodriguez G, Wellmann IA, Orias M, Rivera M, Reyes MV, Onuma O, Ramroop S, Khan T, Gonzalez YV, Barroso WKS, Plavnik FL, Zuniga E, Grassani AM, Tajer C, Zaidel E, Marin MJ, Cyr-Philbert S, Amorin I, Diaz Aguilera MA, Bortolotto L, Avezum A, Ribeiro ALP, Tobe S, Aumala T, Angell S, Lavados P, Martins SO, Echeverri AM, Jaffe MG, Prabhakaran D,Parati G, Zhang XH, Rodgers A, Yusuf S, Whelton PK, Ordunez P. Candidate Interventions for Integrating Hypertension and Cardiovascular-Kidney-Metabolic Care in Primary Health Settings: HEARTS 2.0 Phase 1. Global Heart. 2025; 20(1): 45. DOI: https://doi.org/10.5334/gh.142822118179 (Electrónico)22118160 (Impreso)https://hdl.handle.net/20.500.12442/16630https://doi.org/10.5334/gh.1428https://globalheartjournal.com/articles/1428/files/683599615fc84.pdfBackground: HEARTS in the Americas is the regional adaptation of the WHO Global HEARTS Initiative, aimed at helping countries enhance hypertension and cardiovascular disease (CVD) risk management in primary care settings. Its core implementation tool, the HEARTS Clinical Pathway, has been adopted by 28 countries. To improve the care of hypertension, diabetes, and chronic kidney disease (CKD), HEARTS 2.0 was developed as a three-phase process to integrate evidence-based interventions into a unified care pathway, ensuring consistency across fragmented guidelines. This paper focuses on Phase 1, highlighting targeted interventions to improve and update the HEARTS Clinical Pathway. Methods: First, the coordinating group defined the project’s scope, objectives, principles, methodological framework, and tools. Second, international experts from different disciplines proposed interventions to enhance the HEARTS Clinical Pathway. Third, the coordinating group harmonized these proposals into unique interventions. Fourth, experts appraised the appropriateness of the proposed interventions on a 1-to 9 scale using the adapted RAND/UCLA Appropriateness Method. Finally, interventions with a median score above 6 were deemed appropriate and selected as candidates to enhance the HEARTS Clinical Pathway. Results: Building on the existing HEARTS Clinical Pathway, 45 unique interventions were selected, including community-based screening, early detection and management of risk factors, lower blood pressure thresholds for diagnosing hypertension in high CVD-risk patients, reinforcement of single-pill combination therapy, inclusion of sodium-glucose cotransporter-2 inhibitors for patients with diabetes, CKD, or heart failure, expanded roles for non-physician health workers in team-based care, and strengthened clinical documentation, monitoring, and evaluation.pdfengUbiquity PressAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Global HeartVol. 20 No. 1, (2025)Candidate Interventions for Integrating Hypertension and Cardiovascular-Kidney-Metabolic Care in Primary Health Settings: HEARTS 2.0 Phase 1info:eu-repo/semantics/articleArtículo científicohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_2df8fbb1HypertensionPrimary Health CareCardiovascular DiseasesDiabetes mellitusRenal InsufficiencyChronicStrokeKhan T, Moran AE, Perel P, Whelton PK, Brainin M, Feigin V, et al. The HEARTS partner forum supporting implementation of HEARTS to treat and control hypertension. Front Public Health. 2023;24(11):1146441. DOI: https://doi.org/10.3389/fpubh.2023.1146441Ordunez P, Campbell NRC, DiPette DJ, Jaffe MG, Rosende A, Martinez R, et al. HEARTS in the Americas: Targeting health system change to improve population hypertension control. Curr Hypertens Rep. 2024;26(4):141–156. DOI: https://doi.org/10.1007/s11906-023-01286-wMoran AE, Gupta R, Global Hearts Initiative Collaborators. Implementation of Global Hearts Hypertension Control Programs in 32 low- and middle-income countries: JACC International. J Am Coll Cardiol. 2023;82(19):1868–1884. DOI: https://doi.org/10.1016/j.jacc.2023.08.043Martinez R, Soliz P, Campbell NRC, Lackland DT, Whelton PK, Ordunez P. Association between population hypertension control and ischemic heart disease and stroke mortality in 36 countries of the Americas, 1990–2019: An ecological study. Rev Panam Salud Publica. 2022;46:e143. DOI: https:// doi.org/10.26633/RPSP.2022.143Rosende A, DiPette D, Brettler J, Rodríguez G, Zuniga E, Connell K, et al. HEARTS in the Americas appraisal checklist and clinical pathway for comprehensive hypertension management in primary care. Rev Panam Salud Publica. 2022;2(46):e125. DOI: https://doi.org/10.26633/RPSP.2022.125Campbell NRC, Paccot Burnens M, Whelton PK, Angell SY, Jaffe MG, Cohn J, et al. 2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the region of the Americas. Lancet Reg Health Am. 2022;9. DOI: https://doi.org/10.1016/j. lana.2022.100219Brettler JW, Arcila GPG, Aumala T, Best A, Campbell NR, Cyr S, et al. Drivers and scorecards to improve hypertension control in primary care practice: Recommendations from the HEARTS in the Americas Innovation Group. Lancet Reg Health Am. 2022 May;9. DOI: https://doi.org/10.1016/j. lana.2022.100223DiPette DJ, Goughnour K, Zuniga E, Skeete J, Ridley E, Angell S, et al. Standardized treatment to improve hypertension control in primary health care: the HEARTS in the Americas initiative. J Clin Hypertens. 2020;22(12):2285–2295. DOI: https://doi.org/10.1111/jch.14072DiPette DJ, Skeete J, Ridley E, Campbell NRC, Lopez-Jaramillo P, Kishore SP, et al. Fixed-dose combination pharmacologic therapy to improve hypertension control worldwide: Clinical perspective and policy implications. J Clin Hypertens (Greenwich). 2019;21(1):4–15. DOI: https://doi.org/10.1111/ jch.13426Ordunez P, Tajer C, Gaziano T, Rodriguez YA, Rosende A, Jaffe MG. The HEARTS app: A clinical tool for cardiovascular risk and hypertension management in primary health care. Rev Panam Salud Publica. 2022;28(46):e12. DOI: https://doi.org/10.26633/RPSP.2022.12Rosende A, DiPette DJ, Martinez R, Brettler JW, Rodriguez G, Zuniga E, et al. HEARTS in the Americas clinical pathway. Strengthening the decision support system to improve hypertension and cardiovascular disease risk management in primary care settings. Front Cardiovasc Med. 2023;10:1102482. DOI: https://doi.org/10.3389/fcvm.2023.1102482Ordunez P, Lombardi C, Picone DS, Brady TM, Campbell NRC, Moran AE, et al. HEARTS in the Americas: A global example of using clinically validated automated blood pressure devices in cardiovascular disease prevention and management in primary health care settings. J Hum Hypertens. 2023;37(2):126–129. DOI: https://doi.org/10.1038/s41371-022-00659-zRangaswami J, Bhalla V, Blair JEA, Chang TI, Costa S, Lentine KL, et al. on behalf of the American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Clinical Cardiology. Cardiorenal syndrome: Classification, pathophysiology, diagnosis, and treatment strategies: A scientific statement from the American Heart Association. Circulation. 2019;139:e840–e878. DOI: https://doi.org/10.1161/CIR.0000000000000664Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS, et al. American Heart Association. A synopsis of the evidence for the science and clinical management of cardiovascular kidney-metabolic (CKM) syndrome: A scientific statement from the American Heart Association. Circulation. 2023;148(20):1636–1664. DOI: https://doi.org/10.1161/CIR.0000000000001186PAHO. Better Care for NCDs: Accelerating Actions in Primary Health Care. [Internet]. Available at: https://www.paho.org/en/documents/better-care-ncds-accelerating-actions-primary-health-care. (Access: 12 – Nov – 2024).Brook RH, Chassin MR, Fink A, Solomon DH, Kosecoff J, Park RE. A method for the detailed assessment of the appropriateness of medical technologies. Int J Technol Assess Health Care. 1986;2(1):53–63. DOI: https://doi.org/10.1017/S0266462300002774Satheesh G, Dhurjati R, Huffman MD, Rosende A, Rodgers A, Prabhakaran D, et. Al. Standardized treatment protocols for hypertension: Global availability, characteristics, and alignment with the hypertension guideline recommendations. J Hypertens. 2024;42(5):902–908. DOI: https://doi. org/10.1097/HJH.0000000000003636Ordunez P, Campbell NRC, Giraldo Arcila GP, Angell SY, Lombardi C, Brettler JW, et al. HEARTS in the Americas: Innovations for improving hypertension and cardiovascular disease risk management in primary care. Rev Panam Salud Publica. 2022;46:e96. PMID: 35855441; PMCID: PMC9288223. DOI: https://doi.org/10.26633/RPSP.2022.96Cheung AK, Whelton PK, Muntner P, Schutte AE, Moran AE, Williams B, et al. International consensus on standardized clinic blood pressure measurement – a call to action. Am J Med. 2023;136(5):438–445.e1. DOI: https://doi.org/10.1016/j.amjmed.2022.12.015Sharman JE, Ordunez P, Brady T, Parati G, Stergiou G, Whelton PK, et al. The urgency to regulate validation of automated blood pressure measuring devices: a policy statement and call to action from the world hypertension league. J Hum Hypertens. 2023;37(2):155–159. DOI: https://doi. org/10.1038/s41371-022-00747-0Whelton PK, Picone DS, Padwal R, Campbell NRC, Drawz P, Rakotz MK, et al. Global proliferation and clinical consequences of non-validated automated BP devices. J Hum Hypertens. 2023;37(2):115–119. DOI: https://doi.org/10.1038/s41371-022-00667-zPicone DS, Campbell NRC, Schutte AE, Olsen MH, Ordunez P, Whelton PK, et al. Validation status of blood pressure measuring devices sold globally. JAMA. 2022;327(7):680–681. DOI: https://doi. org/10.1001/jama.2021.24464Lombardi C, Picone DS, Sharman JE, Campbell NRC, Farias R, Guerre S, et al. Country experiences on the path to exclusive use of validated automated blood pressure measuring devices within the HEARTS in the Americas Initiative. J Hum Hypertens. 2023;37(2):120–125. Epub 2022 Jul 11. PMID: 35817799; PMCID: PMC9957722. DOI: https://doi.org/10.1038/s41371-022-00706-9Whelton PK, O’Connell S, Mills KT, He J. Optimal antihypertensive systolic blood pressure: A systematic review and meta-analysis. Hypertension. 2024;81(11):2329–2339. DOI: https://doi. org/10.1161/HYPERTENSIONAHA.124.23597Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117–S314. DOI: https://doi.org/10.1016/j.kint.2023.10.018World Health Organization (September 19, 2023). Global report on hypertension: the race against a silent killer. [Internet]. Available at: https://www.who.int/publications/i/item/9789240081062GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: A systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402(10397):203–234. DOI: https://doi.org/10.1016/S0140- 6736(23)01301-6. Epub 2023 Jun 22. Erratum in: Lancet. 2023 Sep 30;402(10408):1132. DOI: https://doi.org/10.1016/S0140-6736(23)02044-5NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: A pooled analysis of 1101 population-representative studies with 82 million participants. Lancet. 2024;S0140-6736(24)02317-1. DOI: https://doi.org/10.1016/S0140- 6736(24)02317-1Liu J, Li Y, Ge J, Yan X, Zhang H, Zheng X, et al. ESPRIT Collaborative Group. Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial. Lancet. 2024;404(10449):245–255. DOI: https://doi.org/10.1016/S0140-6736(24)01028-6Cheung AK, Chang TI, Cushman WC, Furth SL, Hou FF, Ix JH, et al. Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int. 2021;99(3):559–569. DOI: https://doi.org/10.1016/j.kint.2020.10.026Jin Y, Wang K, Xiao B, Wang M, Gao X, Zhang J, et al. Global burden of atrial fibrillation/flutter due to high systolic blood pressure from 1990 to 2019: Estimates from the global burden of disease study 2019. J Clin Hypertens (Greenwich). 2022;24(11):1461–1472. DOI: https://doi.org/10.1111/jch.14584Dong XJ, Wang BB, Hou FF, Jiao Y, Li HW, Lv SP, et al. Global burden of atrial fibrillation/atrial flutter and its attributable risk factors from 1990 to 2019. Europace. 2023;25(3):793–803. DOI: https://doi. org/10.1093/europace/euac237Welton NJ, McAleenan A, Thom HH, Davies P, Hollingworth W, Higgins JP, et al. Screening strategies for atrial fibrillation: A systematic review and cost-effectiveness analysis. Health Technol Assess. 2017;21(29):1–236. DOI: https://doi.org/10.3310/hta212902023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2024;83(1):109–279. DOI: https://doi.org/10.1016/j. jacc.2023.08.017Freedman B, Hindricks G, Banerjee A, Baranchuk A, Ching CK, Du X, et al. World Heart Federation Roadmap on Atrial Fibrillation – A 2020 Update. Glob Heart. 2021;16(1):41. DOI: https://doi. org/10.5334/gh.1023Niiranen T, Schnabel R, Schutte AE, Biton Y, Boriani G, Buckley C, et al. Hypertension and atrial fibrillation: A frontier Review from the AF-SCREEN International Collaboration. Circulation. 2025;151(12): 863–877. DOI: https://doi.org/10.1161/CIRCULATIONAHA.124.071047Neal B, Wu Y, Feng X, Zhang R, Zhang Y, Shi J, et al. Effect of salt substitution on cardiovascular events and death. N Engl J Med. 2021;385(12):1067–1077. DOI: https://doi.org/10.1056/ NEJMoa2105675Aminde LN, Nugraheni WP, Mubasyiroh R, Rachmawati T, Dwirahmadi F, Martini S, et al. Cost effectiveness analysis of low-sodium potassium-rich salt substitutes in Indonesia: An equity modelling study. Lancet Reg Health Southeast Asia. 2024;26:100432. DOI: https://doi.org/10.1016/j. lansea.2024.100432Marklund M, Singh G, Greer R, Cudhea F, Matsushita K, Micha R, et al. Estimated population wide benefits and risks in China of lowering sodium through potassium enriched salt substitution: Modelling study. BMJ. 2020;369:m824. DOI: https://doi.org/10.1136/bmj.m824Bernabe-Ortiz A, Sal Y, Rosas VG, Ponce-Lucero V, Cárdenas MK, Carrillo-Larco RM, Diez-Canseco F, et al. Effect of salt substitution on community-wide blood pressure and hypertension incidence. Nat Med. 2020;26(3):374–378. DOI: https://doi.org/10.1038/s41591-020-0754-2Yuan Y, Jin A, Neal B, Feng X, Qiao Q, Wang H, et al. Salt substitution and salt-supply restriction for lowering blood pressure in elderly care facilities: A cluster-randomized trial. Nat Med. 2023;29(4):973–981. DOI: https://doi.org/10.1038/s41591-023-02286-8Arsenijevic J, Groot W. Physical activity on prescription schemes (PARS): Do programme characteristics influence effectiveness? Results of a systematic review and meta-analyses. BMJ Open. 2017;7(2):e012156. DOI: https://doi.org/10.1136/bmjopen-2016-012156Patterson R, McNamara E, Tainio M, de Sá TH, Smith AD, Sharp SJ, et al. Sedentary behaviour and risk of all-cause, cardiovascular and cancer mortality, and incident type 2 diabetes: A systematic review and dose response meta-analysis. Eur J Epidemiol. 2018;33(9):811–829. DOI: https://doi. org/10.1007/s10654-018-0380-12016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315–2381. DOI: https://doi.org/10.1093/eurheartj/ ehw1062019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):e596–e646. DOI: https://doi.org/10.1161/CIR.0000000000000678Skotsimara G, Antonopoulos AS, Oikonomou E, Siasos G, Ioakeimidis N, Tsalamandris S, et al. Crdiovascular effects of electronic cigarettes: A systematic review and meta-analysis. Eur J Prev Cardiol. 2019;26(11):1219–1228. DOI: https://doi.org/10.1177/2047487319832975Jeffers AM, Glantz S, Byers AL, Keyhani S. Association of cannabis use with cardiovascular outcomes among US adults. J Am Heart Assoc. 2024;13(5):e030178. Epub 2024 Feb 28. PMID: 38415581; PMCID: PMC10944074. DOI: https://doi.org/10.1161/JAHA.123.030178Rodgers A, Salam A, Schutte AE, Cushman WC, de Silva HA, Di Tanna GL, et al. Efficacy and safety of a novel low-dose triple single-pill combination compared with placebo for initial treatment of hypertension. J Am Coll Cardiol. 2024;84(24):2393–2403. DOI: https://doi.org/10.1016/j. jacc.2024.08.0252017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):e13–e115. DOI: https://doi.org/10.1161/HYP.0000000000000065. Epub 2017 Nov 13. Erratum in: Hypertension. 2018 Jun;71(6):e140–e144. DOI: https://doi.org/10.1161/ HYP.00000000000000762024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension. Eur J Intern Med. 2024;126:1–15. DOI: https://doi.org/10.1016/j.ejim.2024.05.0332024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45(38):3912–4018. DOI: https://doi.org/10.1093/eurheartj/ehae178WHO Model List of Essential Medicines – 23rd list, 2023. WHO/MHP/HPS/EML/2023.02. [Internet]. Available at: https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2023.02O’Hagan E, McIntyre D, Nguyen T, Tan KM, Hanlon P, Siddiqui M, et al. A cross-sectional survey of fixed-dose combination antihypertensive medicine prescribing in twenty-four countries, including qualitative insights. Glob Heart. 2024;19(1):73. DOI: https://doi.org/10.5334/gh.1353Souza KM, Giron N, Vallini J, Hallar K, Ordunez P, Rosende A, et al. Barriers to access to antihypertensive medicines: insights from the HEARTS initiative in Latin American and Caribbean region. J Pharm Policy Pract. 2024;17(1):2379045. DOI: https://doi.org/10.1080/20523211.2024.2379 045McGuire DK, Shih WJ, Cosentino F, Charbonnel B, Cherney DZI, Dagogo-Jack S, et al. Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: A meta analysis. JAMA Cardiol. 2021;6(2):148–158. DOI: https://doi.org/10.1001/jamacardio.2020AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/ American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73(24):3168–3209. DOI: https://doi.org/10.1016/j.jacc.2018.11.002. Erratum in: J Am Coll Cardiol. 2019;73(24):3234–3237.PAHO Strategic Fund Product List. Aug. 2023. Available at: https://www.paho.org/sites/default/files/ strategic-fund-product-list-230821_0.pdfLasserson DS, Buclin T, Glasziou P. How quickly should we titrate antihypertensive medication? Systematic review modelling blood pressure response from trial data. Heart. 2011;97(21):1771–1775. DOI: https://doi.org/10.1136/hrt.2010.221473Boima V, Doku A, Agyekum F, Tuglo LS, Agyemang C. Effectiveness of digital health interventions on blood pressure control, lifestyle behaviours and adherence to medication in patients with hypertension in low-income and middle-income countries: A systematic review and meta-analysis of randomised controlled trials. EClinicalMedicine. 2024;69:102432. DOI: https://doi.org/10.1016/j. eclinm.2024.102432He J, Ouyang N, Guo X, Sun G, Li Z, Mu J, et al. Effectiveness of a non-physician community health care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): An open-label, blinded-endpoint, cluster-randomised trial. Lancet. 2023;401(10380):928– 938. DOI: https://doi.org/10.1016/S0140-6736(22)02603-4Giraldo GP, Joseph KT, Angell SY, Campbell NRC, Connell K, DiPette DJ, et al. Mapping stages, barriers and facilitators to the implementation of HEARTS in the Americas initiative in 12 countries: A qualitative study. J Clin Hypertens (Greenwich). 2021;23(4):755–765. DOI: https://doi.org/10.1111/ jch.14157Schwalm JD, McCready T, Lopez-Jaramillo P, Yusoff K, Attaran A, Lamelas P, et al. A community based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): A cluster-randomised controlled trial. Lancet. 2019;394(10205):1231–1242. DOI: https://doi. org/10.1016/S0140-6736(19)31949-XGarcía-Zamora S, Pulido L. Vaccines in cardiology, an underutilized strategy to reduce the residual cardiovascular risk. Arch Peru Cardiol Cir Cardiovasc. 2024;5(1):29–39. DOI: https://doi.org/10.47487/ apcyccv.v5i1.349ORIGINALPDF.pdfPDF.pdfapplication/pdf2789454https://bonga.unisimon.edu.co/bitstreams/0d7dac3d-e85f-44b7-85a2-5cef8b960dc4/download757c89011daee329c899d390fcf67c41MD51CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8899https://bonga.unisimon.edu.co/bitstreams/2cdbb472-fb91-43a0-99e8-e3a12d11ca99/download3b6ce8e9e36c89875e8cf39962fe8920MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-8381https://bonga.unisimon.edu.co/bitstreams/9247e97b-15a1-463d-acf7-3451f8fc431b/download733bec43a0bf5ade4d97db708e29b185MD53TEXTPDF.pdf.txtPDF.pdf.txtExtracted texttext/plain80920https://bonga.unisimon.edu.co/bitstreams/28f7a355-a6a1-4f5c-99cd-7588000d4c87/download77c9f58d6a1c0c85d98821b5ba1c7a46MD54THUMBNAILPDF.pdf.jpgPDF.pdf.jpgGenerated Thumbnailimage/jpeg6428https://bonga.unisimon.edu.co/bitstreams/96f415a9-d474-4429-8e80-39516f334c24/downloada02dd1c329763fc4017d6365b098c87aMD5520.500.12442/16630oai:bonga.unisimon.edu.co:20.500.12442/166302025-05-29 03:02:56.221http://creativecommons.org/licenses/by-nc-nd/4.0/Attribution-NonCommercial-NoDerivatives 4.0 Internationalopen.accesshttps://bonga.unisimon.edu.coRepositorio Digital Universidad Simón Bolívarrepositorio.digital@unisimon.edu.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 |